Salzmann Peter — SEC Form 4 filings
SEC reporting owner CIK 1796309. 20 Form 4 filings on record with FilingPulse; latest filed 2025-04-17.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-01-09 to 2025-04-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 16 filings — 196,672 shares, $5,082,186 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 26,365 shares @ $28.80 ($759,312) in Immunovant, Inc., filed 2024-04-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Executive Officer, Director | 18 | — | 20 legs · 196,672 sh · $5,082,186 | 4 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | 2 | — | — | 2 |
Form 4 filings — Salzmann Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-17 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,321 @ $14.89 | EDGAR |
| 2025-04-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 28,094 @ $12.99 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 265,820 @ $0 · Grant/award (A): 374,395 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 15,439 @ $20.86 | EDGAR |
| 2025-01-17 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,352 @ $23.81 · Sale (S): 415 @ $24.19 | EDGAR |
| 2025-01-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 5,105 @ $24.10 | EDGAR |
| 2024-11-22 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 16,692 @ $25.45 | EDGAR |
| 2024-10-18 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 9,095 @ $28.79 | EDGAR |
| 2024-10-11 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 4,460 @ $29.56 | EDGAR |
| 2024-08-23 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 14,470 @ $31.84 · Sale (S): 598 @ $32.32 | EDGAR |
| 2024-07-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,175 @ $29.64 · Sale (S): 510 @ $30.55 | EDGAR |
| 2024-07-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 4,619 @ $28.06 | EDGAR |
| 2024-06-03 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 2,783 @ $0 | EDGAR |
| 2024-05-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 16,163 @ $29.65 | EDGAR |
| 2024-05-20 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 2,783 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 26,365 @ $28.80 · Sale (S): 7,714 @ $29.94 | EDGAR |
| 2024-04-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 4,807 @ $31.18 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 160,534 @ $0 · Grant/award (A): 200,667 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 13,454 @ $36.15 | EDGAR |
| 2024-01-09 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,824 @ $38.59 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796309 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →